Cinobufagin, used for the treatment of cancer pain, relieved cancer pain by upregulating the expressions of both mu-opioid receptors and beta-END in the hind paw tumor and tissues placed close to the tumor in a rat model of paw bone cancer pain [131]. The gene discussed is OPRM1; the disease is bone neoplasm.